Jana Medical Company (TADAWUL:9616)
Saudi Arabia
· Delayed Price · Currency is SAR
13.00
-0.22 (-1.66%)
Jun 26, 2025, 3:13 PM AST
Jana Medical Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 5.92 | 5.41 | 5.22 |
| Depreciation & Amortization | 0.38 | 0.38 | 0.22 |
| Other Amortization | 0 | 0 | 0 |
| Provision & Write-off of Bad Debts | 1.12 | 3.18 | 0.65 |
| Other Operating Activities | 1.87 | 0.19 | 0.77 |
| Change in Accounts Receivable | -28.99 | -31.16 | -32.31 |
| Change in Inventory | 6.39 | 8.74 | -7.89 |
| Change in Accounts Payable | 8.58 | 0.64 | -0.09 |
| Change in Other Net Operating Assets | 15.31 | 16.54 | -2.98 |
| Operating Cash Flow | 10.57 | 3.92 | -36.41 |
| Capital Expenditures | -0.02 | -0.16 | -0.36 |
| Sale (Purchase) of Intangibles | -0.02 | -0.08 | -0 |
| Investing Cash Flow | -0.04 | -0.24 | -0.36 |
| Long-Term Debt Issued | - | 48.03 | 29.75 |
| Short-Term Debt Repaid | - | -6.78 | -5.72 |
| Long-Term Debt Repaid | - | -44.88 | -8.76 |
| Total Debt Repaid | -71.27 | -51.66 | -14.47 |
| Net Debt Issued (Repaid) | -10.61 | -3.63 | 15.28 |
| Issuance of Common Stock | - | - | 22.06 |
| Financing Cash Flow | -10.61 | -3.63 | 37.34 |
| Net Cash Flow | -0.08 | 0.05 | 0.57 |
| Free Cash Flow | 10.55 | 3.76 | -36.77 |
| Free Cash Flow Margin | 16.40% | 6.13% | -85.42% |
| Free Cash Flow Per Share | 4.11 | 1.47 | -18.29 |
| Cash Interest Paid | 7.09 | 7.09 | 2.04 |
| Levered Free Cash Flow | - | -8.58 | - |
| Unlevered Free Cash Flow | - | -5.52 | - |
| Change in Net Working Capital | - | 13.5 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.